[Experimental studies on mechanism of inhibition of thrombocyte aggregation caused by sulfonyl ureas. 1. Problems and methods].
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001786:Blood Glucose / Q000032:analysis; D000242:Cyclic AMP / Q000378:metabolism; D003864:Depression, Chemical; D066298:In Vitro Techniques; D007328:Insulin / Q000097:blood; D008099:Liver / Q000378:metabolism; D008297:Male; D008722:Methods; D010973:Platelet Adhesiveness / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000494:pharmacology; D011485:Protein Binding; D051381:Rats; D013453:Sulfonylurea Compounds / Q000494:pharmacology*; D013696:Temperature; D013806:Theophylline / Q000494:pharmacology; D014044:Tolbutamide / Q000494:pharmacology; D014316:Tritium
D001786:Blood Glucose; D007328:Insulin; D011453:Prostaglandins; D013453:Sulfonylurea Compounds; D014316:Tritium; D000244:Adenosine Diphosphate; D014044:Tolbutamide; D013806:Theophylline; D000242:Cyclic AMP; D001241:Aspirin
Experimentelle Untersuchungen zum Mechanismus der durch Sulfonylharnstoffe verursachten Hemmung der Thrombozytenaggregation. 1. Mitteilung: Problemstellung und Methoden